MedTech ON AIR

Patrick Boisseau, Director General Industry Strategic Initiatives at MedTech Europe, explains what is the Innovative Health Initiative, the world largest public-private partnership in life sciences, launched together by four European trade associations, including MedTech Europe.

Serge Bernasconi, CEO of MedTech Europe, joined MedTech ON AIR to reflect on 2021 and give his insights on the medical technology sector for the year ahead, and priorities for the European medical technology trade association.

Welcome to our new episode of MedTech ON AIR where Michael Strübin, MedTech Europe's Director Digital Health, talks about the benefits of health data for research and innovation in health technologies and how the European Health Data Space could provide what is needed to achieve the digital transformation of healthcare.

MedTech Europe's Director for International Affairs, Jesus Rueda Rodriguez, talks about the new and existing healthcare practices in the light of the COVID-19 pandemic.

The new in vitro Diagnostic Medical Devices Regulation will come into force in 2022. This new piece of legislation represents a major overhaul of the regulatory system and together with Oliver Bizazza, MedTech Europe Director General for Industrial Policies, we look into the work still needed before the IVDR comes into place on 26 May 2022.

As we approach the end of the year, Europe is faced with a second wave of coronavirus, with many states going back into lockdown. The situation seems to reflect what happened in March when COVID-19 first appeared in Europe, and governments took drastic measures to keep their healthcare systems running. However, some things have changed since the first wave. Among them, the readiness of healthcare systems and industry. In this episode of MedTech ON AIR, we explore this and more with MedTech Europe's Director for International Affairs, Jesus Rueda Rodriguez.

Together with MedTech Europe's Director for Research and Innovation, Patrick Boisseau, we look at the European research and innovation landscape during a year of both crisis and transition. Will the lessons learned from COVID-19 be incorporated in the new programmes? What are the coming changes for medical technology in the research space? Listen to episode 4 of MedTech ON AIR to find the answers to these and other questions.

MedTech Europe International Affairs Director, Jesus Rueda Rodriguez, helps us shed some light on the so-called ‘Phase 2’ or deconfinement and how medical technology plays a role to inform and shape European and national strategies. Also in this episode: how will healthcare systems adapt to the ‘new normal’? How we can make sure that people affected by chronic conditions or other illnesses receive the best possible care?

The coronavirus outbreak has placed focus on the mechanisms and technologies that help us prevent and fight these crises. Medical technology plays an important role in the combat against COVID19, supporting patients, systems and healthcare workers in different ways. In this episode, we talk to Jesus Rueda Rodriguez and we take a closer look at the what medical technology can do and how it is contributing to the international response against coronavirus.

The three-year transition period for the new Medical Device Regulation will end on 26 May 2020, and the new In Vitro Diagnostic Regulation will come into force in 2022. These new pieces of legislation bring changes to one of the pillars of the medical technology sector: the CE marking process. In this episode, we speak to Oliver Bisazza about what this process is, how it changes and what the medtech industry has to say about it.